Ketamine-xylazine-acepromazine compared with isoflurane for anesthesia during liver transplantation in rodents

Journal of the American Association for Laboratory Animal Science

Volumn 49, Issue 1, 2010, Pages 45-51

  He, Songqing ^a,b   Atkinson, Carl ^a   Qiao, Fei ^a   Chen, Xiaoping ^b   Tomlinson, Stephen ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ALANINE AMINOTRANSFERASE; BILIRUBIN; BROXURIDINE; INTERLEUKIN 6; ISOFLURANE; KETAMINE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; XYLAZINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LIVER FUNCTION; LIVER GRAFT; LIVER INJURY; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; MITOSIS INDEX; MOUSE; NONHUMAN; RAT;

ACEPROMAZINE; ANESTHESIA; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, COMBINED; ANESTHETICS, INHALATION; ANIMALS; INJECTIONS, INTRAPERITONEAL; ISOFLURANE; KETAMINE; LIVER TRANSPLANTATION; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED LEW; TIME FACTORS; XYLAZINE;

MUS; RATTUS; RODENTIA;

EID: 76349122008     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Arras M, Autenried P, Rettich A, Spaeni D, Rulicke T. 2001. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comp Med 51:443-456.
2. Asokan R, Hua J, Young KA, Gould HJ, Hannan JP, Kraus DM, Szakonyi G, Grundy GJ, Chen XS, Crow MK, Holers VM. 2006. Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFNα: a potential role in systemic lupus erythematosus. J Immunol 177:383-394.
3. Bovill JG. 2008. Inhalation anaesthesia: from diethyl ether to xenon. Handb Exp Pharmacol 182:121-142.
4. Buitrago S, Martin TE, Tetens-Woodring J, Belicha-Villanueva A, Wilding GE. 2008. Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice. J Am Assoc Lab Anim Sci 47:11-17.
5. Conzelmann LO, Zhong Z, Bunzendahl H, Wheeler MD, Lemasters JJ. 2003. Reduced-size liver transplantation in the mouse. Transplantation 76:496-501.
6. Englehart MS, Allison CE, Tieu BH, Kiraly LN, Underwood SA, Muller PJ, Differding JA, Sawai RS, Karahan A, Schreiber MA. 2008. Ketamine-based total intravenous anesthesia versus isoflurane anesthesia in a swine model of hemorrhagic shock. J Trauma 65:901-908, discussion 908-909.
7. Fabrikant JI. 1968. The kinetics of cellular proliferation in regenerating liver. J Cell Biol 36:551-565.
8. Flondor M, Hofstetter C, Boost KA, Betz C, Homann M, Zwissler B. 2008. Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response. Eur Surg Res 40:1-6.
9. Gordon SM. 2007. Translating science into the art of acute pain management. Compend Contin Educ Dent 28:248-260; quiz 261, 282.
10. Helmy SA, Al-Attiyah RJ. 2000. The effect of halothane and isoflurane on plasma cytokine levels. Anaesthesia 55:904-910.
11. Hill GE, Anderson JL, Lyden ER. 1998. Ketamine inhibits the proinflammatory cytokine-induced reduction of cardiac intracellular cAMP accumulation. Anesth Analg 87:1015-1019.
12. Institute of Laboratory Animal Resources. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
13. Kawasaki T, Ogata M, Kawasaki C, Ogata J, Inoue Y, Shigematsu A. 1999. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth Analg 89:665-669.
14. Ke JJ, Zhan J, Feng XB, Wu Y, Rao Y, Wang YL. 2008. A comparison of the effect of total intravenous anaesthesia with propofol and remifentanil and inhalational anaesthesia with isoflurane on the release of pro- and antiinflammatory cytokines in patients undergoing open cholecystectomy. Anaesth Intensive Care 36:74-78.
15. Koga K, Ogata M, Takenaka I, Matsumoto T, Shigematsu A. 1994. Ketamine suppresses tumor necrosis factor α activity and mortality in carrageenan-sensitized endotoxin shock model. Circ Shock 44:160-168.
16. Larsen B, Hoff G, Wilhelm W, Buchinger H, Wanner GA, Bauer M. 1998. Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood. Anesthesiology 89:1218-1227.
17. Lee HT, Emala CW, Joo JD, Kim M. 2007. Isoflurane improves survival and protects against renal and hepatic injury in murine septic peritonitis. Shock 27:373-379.
18. Lee HT, Kim M, Kim M, Kim N, Billings FT 4th, D'Agati VD, Emala CW Sr. 2007. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice. Am J Physiol Renal Physiol 293:F713-F722.
19. Man K, Lo CM, Ng IO, Wong YC, Qin LF, Fan ST, Wong J. 2001. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 136:280-285.
20. Neder Meyer T, Lazaro Da Silva A. 2004. Ketamine reduces mortality of severely burnt rats, when compared to midazolam plus fentanyl. Burns 30:425-430.
21. Omura T, Ascher NL, Emond JC. 1996. Fifty-percent partial liver transplantation in the rat. Transplantation 62:292-293.
22. Peng Y, Gong JP, Liu CA, Wang W, Lan YN. 2003. Selection of anesthetic method in setting up the model of orthotopic liver transplantation in rats. Chin J Gen Surg 12:673-676.
23. Rainsford KD. 2007. Antiinflammatory drugs in the 21st century. Subcell Biochem 42:3-27.
24. Reuben SS, Buvanendran A. 2007. Preventing the development of chronic pain after orthopaedic surgery with preventive multimodal analgesic techniques. J Bone Joint Surg Am 89:1343-1358.
25. Roytblat L, Talmor D, Rachinsky M, Greemberg L, Pekar A, Appelbaum A, Gurman GM, Shapira Y, Duvdenani A. 1998. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth Analg 87:266-271.
26. Sakai T, Ichiyama T, Whitten CW, Giesecke AH, Lipton JM. 2000. Ketamine suppresses endotoxin-induced NFκB expression. Can J Anaesth 47:1019-1024.
27. Shaked G, Czeiger D, Dukhno O, Levy I, Artru AA, Shapira Y, Douvdevani A. 2004. Ketamine improves survival and suppresses IL6 and TNFα production in a model of Gram-negative bacterial sepsis in rats. Resuscitation 62:237-242.
28. Strey CW, Markiewski M, Mastellos D, Tudoran R, Spruce LA, Greenbaum LE, Lambris JD. 2003. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J Exp Med 198:913-923.
29. Suliburk JW, Helmer KS, Gonzalez EA, Robinson EK, Mercer DW. 2005. Ketamine attenuates liver injury attributed to endotoxemia: role of cyclooxygenase 2. Surgery 138:134-140.
30. Sun J, Wang XD, Liu H, Xu JG. 2004. Ketamine suppresses endotoxin-induced NFκB activation and cytokines production in the intestine. Acta Anaesthesiol Scand 48:317-321.
31. Tian Y, Graf R, Jochum W, Clavien PA. 2003. Arterialized partial orthotopic liver transplantation in the mouse: a new model and evaluation of the critical liver mass. Liver Transpl 9:789-795.
32. Walker JS. 1995. NSAID: an update on their analgesic effects. Clin Exp Pharmacol Physiol 22:855-860.
33. Welberg LA, Kinkead B, Thrivikraman K, Huerkamp MJ, Nemeroff CB, Plotsky PM. 2006. Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. J Am Assoc Lab Anim Sci 45:13-20.
34. Zaugg M, Lucchinetti E, Spahn DR, Pasch T, Garcia C, Schaub MC. 2002. Differential effects of anesthetics on mitochondrial K(ATP) channel activity and cardiomyocyte protection. Anesthesiology 97:15-23.